Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines
- PMID: 2234100
- DOI: 10.1007/BF00166958
Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines
Abstract
Guinea-pig vasa deferentia or hypogastric nerve-vas deferens preparations, preincubated with pargyline (to irreversibly inhibit monoamine oxidase), were exposed to 2.3 mumol/l of unlabelled adrenaline or of 3H-7-(-)-noradrenaline in the presence of hydrocortisone (to inhibit extraneuronal uptake). The vasa deferentia were then mounted in perifusion chambers and subjected to transmural electrical stimulation, electrical stimulation of the nerve, depolarization by potassium (50 mmol/l), or addition of tyramine (40 mumol/l). The evoked overflow of tritium and of unlabelled catecholamines was expressed as a fraction of their tissue content. For all stimuli, the fractional release of the exogenous amines was higher than that of endogenous noradrenaline. Thus, recently incorporated amines are preferentially mobilized irrespective of the particular type of releasing mechanism or the chemical nature of the amine. In vasa deferentia which had been loaded with increasing amounts of adrenaline (by incubating the tissues with adrenaline at concentrations ranging from 0.6 to 160 mumol/l), the fractional release of adrenaline decreased and became closer to that of endogenous noradrenaline. Hence, the access of exogenous catecholamines to the deepest storage sites requires higher concentrations of amines than those needed to reach the more easily releasable pools. Light microscope autoradiographs obtained from slices of vasa deferentia previously loaded with 2.3 mumol/l 3H-(-)-noradrenaline showed that the outer layers were strongly labelled with silver grains whereas the inner layers were poorly marked. It is concluded that recently incorporated amines are preferentially stored in varicosities close to the surface of the tissue and, in comparison with endogenous noradrenaline, are preferentially released from sympathetically innervated organs.
Similar articles
-
Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.J Physiol. 1996 Nov 1;496 ( Pt 3)(Pt 3):731-48. doi: 10.1113/jphysiol.1996.sp021723. J Physiol. 1996. PMID: 8930840 Free PMC article.
-
Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens.Br J Pharmacol. 1984 Mar;81(3):563-9. doi: 10.1111/j.1476-5381.1984.tb10110.x. Br J Pharmacol. 1984. PMID: 6697064 Free PMC article.
-
Further evidence that prostaglandins inhibit the release of noradrenaline from adrenergic nerve terminals by restriction of availability of calcium.Br J Pharmacol. 1976 Dec;58(4):599-603. doi: 10.1111/j.1476-5381.1976.tb08629.x. Br J Pharmacol. 1976. PMID: 1000134 Free PMC article.
-
Do sympathetic nerves release noradrenaline in "quanta"?J Auton Nerv Syst. 2000 Jul 3;81(1-3):236-43. doi: 10.1016/s0165-1838(00)00119-3. J Auton Nerv Syst. 2000. PMID: 10869727 Review.
-
The functional coupling of neuronal and extraneuronal transport with intracellular monoamine oxidase.J Neural Transm Suppl. 1987;23:91-101. doi: 10.1007/978-3-7091-8901-6_6. J Neural Transm Suppl. 1987. PMID: 3295118 Review.
Cited by
-
Electrophysiological and electrochemical analysis of the secretion of ATP and noradrenaline from the sympathetic nerves in rat tail artery: effects of alpha 2-adrenoceptor agonists and antagonists and noradrenaline reuptake blockers.Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):173-86. doi: 10.1007/BF00165299. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1360152
-
Homogeneous or heterogeneous distribution of systemically administered adrenaline: organ dependence.Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):579-83. doi: 10.1007/BF00169179. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8740153
-
Potentiation of potassium-evoked noradrenaline and neuropeptide Y co-release by cardiac energy depletion: role of calcium channels and sodium-proton exchange.Naunyn Schmiedebergs Arch Pharmacol. 1992 Oct;346(4):410-8. doi: 10.1007/BF00171083. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1331814
-
The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.Naunyn Schmiedebergs Arch Pharmacol. 1991 Nov;344(5):520-6. doi: 10.1007/BF00170646. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1811169
-
Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.Br J Pharmacol. 2010 Feb;159(4):797-807. doi: 10.1111/j.1476-5381.2009.00574.x. Epub 2010 Feb 5. Br J Pharmacol. 2010. PMID: 20136837 Free PMC article.